Totally Ansoff Matrix

Totally Ansoff Matrix

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Totally Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Explore the Complete Growth Strategy Behind the Preview

This Totally Ansoff Matrix Analysis gives you a clear view of the company's growth options across market penetration, market development, product development, and diversification. What you see on this page is a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.

Market Penetration

Icon

Renewal of over 90 percent of NHS urgent care contracts

Totally's NHS urgent care renewal rate is over 90%, which shows strong market penetration and sticky demand across the 2025 and 2026 fiscal years. By keeping Integrated Care Board contracts in place, Totally protects a core revenue base from public spending swings and keeps its regional urgent treatment share near 10%. That contract stability also supports cash flow for service upgrades and staffing.

Icon

Reduction of overhead expenses by 15 percent via digitization

Totally is pushing market penetration by cutting overheads 15% through digitization, mainly via automated scheduling and payroll across thousands of clinicians. That lowers admin waste in existing centers and should help lift EBIT margins by Q1 2026. A lower cost to serve each patient also makes Totally's bids sharper in legacy healthcare procurement cycles.

Explore a Preview
Icon

Expansion of existing 111 service capacity by 20 percent

Totally's 20% expansion of existing 111 capacity is a clear market penetration move: it lifts throughput in a known service line, not a new market. By scaling call centers across the Midlands and North, Totally can serve more of the national 111 telephony market while staying inside its current clinical governance model. That matters as public demand for non-emergency medical advice is rising about 5% a year, so more capacity should support higher volumes without the cost and risk of entering new territory.

Icon

Consolidation of subsidiary brands under a single 2026 framework

By folding Vocare and Greenbrook into one 2026 operating model, Totally can present one service line to NHS and other healthcare clients instead of separate brands. That should make cross-selling easier, especially from urgent care into specialist services, and management says the tighter structure can cut the sales cycle for established partners by about 3 months. In market-penetration terms, the gain is simpler buying, faster conversion, and better use of existing client accounts.

Icon

Facility modernization across 12 strategic clinical sites

Totally's modernization of 12 strategic clinical sites should lift market penetration by increasing throughput in dense urban catchments, where demand is highest and wait times hurt retention. Faster patient flow means more billable encounters under fee-for-service contracts, so the same footprint can generate more revenue without opening new sites. It also raises the bar for private competitors, since upgraded clinics can improve satisfaction scores and act as a local defensive moat.

Icon

Same Market, More Volume for Totally

Totally's market penetration is strongest where it already has scale: over 90% NHS urgent care renewal, about 10% regional urgent treatment share, and 20% more 111 capacity in FY2025-FY2026. The 15% overhead cut and 12-site upgrade should lift throughput and make bids cheaper in existing NHS contracts. One point: same market, more volume.

Metric FY2025-FY2026
Urgent care renewal >90%
Regional share ~10%
111 capacity +20%
Overhead cut 15%
Strategic sites upgraded 12

What is included in the product

Word Icon Detailed Word Document
Analyzes Totally's growth options across existing and new products and markets through the Ansoff Matrix framework
Plus Icon
Excel Icon Editable Excel File
Provides a clear Ansoff matrix to quickly ease growth-planning confusion.

Market Development

Icon

Entry into 5 new regional markets in Ireland

Totally's move into 5 Irish counties by 2026 uses its UK urgent care model to win share where clinical demand has outrun supply. The Republic of Ireland's single-payer system still faces long waits, so a regional rollout can capture unmet need faster than a full national launch. It also reduces dependence on the UK market, which has been Totallly's core revenue base.

Icon

Targeting 50 major UK corporations for employee wellness programs

Totally is pushing into the UK private sector by selling its clinical expertise to large employers that want to cut sick leave and speed up access to care. The goal is 50 corporate contracts by end-2025, with on-site and remote health screenings for white-collar staff.

This is a market development play in a higher-margin segment than public contracts, where buyers focus on rapid access rather than pure cost savings. For Totaly, each new employer deal can add recurring screening and triage revenue while broadening its private client base.

Explore a Preview
Icon

Rollout of a 15-unit mobile clinical fleet for rural areas

Totally plc's 15-unit mobile clinical fleet is a clear market development move: it opens rural UK geographies without the cost of new fixed clinics. Management says the units can reach 25,000 new patients a year, creating fresh elective-care and diagnostics revenue from people outside existing clinic clusters.

Icon

Partnerships with 10 new NHS Trusts for surgical insourcing

This is market development: Totally is moving its existing elective care model into new NHS Trust sites, so it can sell the same service in a new setting. By 2026, the plan is to work with 10 more Trusts and use its own clinical staff on weekends to cut surgery backlogs, which gives Totally hospital access without building or running its own hospitals. That lowers capital needs and lets the Company tap a large NHS elective market while staying asset-light.

Icon

Development of an 18-month digital platform for private elective patients

Totally's 18-month portal is a market development play: it adds a new direct-to-consumer channel for self-paying patients who want faster access to physical therapy and minor surgeries. The target is patients who often buy private cover but may choose lower-cost, local care, with Totally aiming to get 5% of elective revenue from this digital segment by 2026.

Icon

Totally scales by expanding its care model into new markets

Totally's market development is about selling existing care models into new geographies and customer groups. In 2025, it is targeting 5 Irish counties, 50 corporate contracts, 10 new NHS Trusts, and 25,000 patients a year from its 15 mobile units. That broadens revenue without building a new care model.

2025 move Target
Ireland 5 counties
Corporate 50 contracts
NHS 10 Trusts
Mobile fleet 25,000 patients

Preview Before You Purchase
Totally Reference Sources

This is the actual Totally Ansoff Matrix analysis document you'll receive after purchase – no sample, no placeholders. The preview below is pulled directly from the full report, so what you see is exactly what you get. Once you complete your purchase, the full, detailed version becomes available instantly.

Explore a Preview

Product Development

Icon

Deployment of 600 virtual ward beds for remote patient monitoring

Totally's 600 virtual ward beds by March 2026 move it into the fast-growing hospital-at-home market, where remote monitoring lets chronic patients leave hospital sooner while staying under clinical oversight. The rollout can free physical beds and turn care into a recurring, technology-enabled monitoring fee, which fits Ansoff's product development: new service, same healthcare base. As an added scale marker, each bed is a paid monitoring slot, so the model should grow with occupancy and patient turnover.

Icon

Integration of AI-driven triage assistants to cut wait times by 4 minutes

Embedding AI-driven triage assistants into clinical assessment software is a product-development move in the Ansoff Matrix: it adds a new capability to the current urgent-care journey. By 2026, the firm aims to cut the first assessment by at least 4 minutes, which should speed patient routing and lift network throughput. The benefit is simple: less waiting, faster clinician decisions, and a smoother visit for both sides.

Explore a Preview
Icon

Establishment of 40 integrated mental health urgent care hubs

Totally's product development step adds 40 integrated mental health urgent care hubs by mid-FY2026, pairing rapid-response mental health support with existing physical care sites. This dual-care model targets a real gap where mental health crises still land in general emergency rooms and slow down treatment for complex cases. In Ansoff terms, it is a product extension that raises service depth without needing a new customer base.

Icon

Launching a suite of 12 types of home-diagnostic testing kits

Launching 12 medical-grade home diagnostic kits fits Ansoff's product development move by adding a new test line for current patients. The kits can screen chronic disease markers and prevention signals before the visit, giving the clinical team data up front and shortening time to action. That matters because home testing already proved scale: Labcorp said at-home collection helped cut friction, and the U.S. home diagnostics market is projected to keep growing at double-digit rates through 2025.

Icon

Opening 8 specialized diabetic care and management centers

Opening eight specialized diabetic care and management centers is a Product Development move: Totally is adding a new service line for long-term condition care, not just urgent visits. The shift fits a market where diabetes cases keep rising, with the International Diabetes Federation putting global adult diabetes at 589 million in 2025. By 2026, these pilot sites should show whether tighter monitoring, education, and follow-up can cut total care costs below standard primary care.

Icon

New Services, Same Patients: Capacity and Speed Surge

Product development in Totally Ansoff Matrix means adding new services to the same care base: 600 virtual ward beds, AI triage, 40 mental health hubs, 12 home kits, and 8 diabetic centres. These FY2025-26 moves lift capacity and speed, with AI cutting first assessment by at least 4 minutes. One line: new service, same patient base.

Move Scale Effect
Virtual wards 600 beds More recurring monitoring
AI triage 4 min faster Quicker routing
Mental health hubs 40 sites Deeper service mix

Diversification

Icon

Licensing clinical workflow SaaS to 5 international healthcare providers

This is diversification: Totally is shifting from labour-heavy clinical services to a licensable SaaS product, so revenue can scale without adding staff one-for-one.

The first phase targets 5 international healthcare providers, with rollout into Australia and the United States by early 2026, which takes the workflow IP beyond the UK.

In Ansoff terms, this is the clearest leap into new product and new market risk, but it also opens higher-margin recurring software revenue if adoption sticks.

Icon

Creation of an international nursing recruitment agency across 3 continents

In 2025, Totally"s move to build an international nursing recruitment agency across three continents fits diversification: it adds a B2B revenue stream beyond its own clinics.

With WHO warning of a projected 10 million health-worker shortfall by 2030, sourcing, training, and placing nurses overseas can help ease shortages while collecting placement fees.

The model also lowers staffing risk for Totally"s internal operations and scales demand across the wider healthcare sector.

Explore a Preview
Icon

Execution of 2 major med-tech patent licensing deals

The execution of 2 major med-tech patent licensing deals shifts the firm from service delivery into the medical hardware ecosystem. It is now building IP around wearable devices and licensing it to global manufacturers.

This is diversification in Ansoff terms: same firm, new product and market risk. By 2026, royalty income should add a high-margin non-operating stream and help offset clinical volatility.

Icon

Inaugurating 4 private wellness and preventative luxury centers

Launching 4 private wellness and preventative luxury centers is market development, not core healthcare delivery. Totally is shifting from public, budget-led care to a private-pay model focused on longevity, aesthetics, and prevention for affluent clients, with no government funding support.

By 2026, the 4 sites will test whether higher-margin elective services can cover premium fit-out, specialist staffing, and low-volume demand better than its traditional model. The real question is simple: will private cash-pay spend be enough to scale beyond a pilot?

Icon

Developing 3 accredited medical education programs for universities

Totally is using its clinical expertise to create and sell 3 accredited education modules for universities, moving into a new professional services stream. The focus on urgent care and clinical governance turns know-how from care delivery into licensable training, which fits Ansoff diversification by reaching a new market with a new offer. By 2026, adoption by 3 major universities could add recurring licensing and accreditation fees, giving Totally a steadier income base than pure service contracts.

Icon

Totally's 2025-26 expansion: new products, new markets

Totally's diversification moves in 2025-26 span software, recruitment, IP licensing, private wellness, and education. That means new products and new markets, not just more of the same. The clearest signal is scale: 5 provider pilots, 3 continents, 2 patent deals, 4 centres, and 3 university modules.

Move 2025-26
Scope New prod/market

Frequently Asked Questions

Totally maintains its leadership by renewing over 90 percent of its NHS contracts through March 2026. The company focuses on the 111 telephony market and local urgent treatment centers to capture demand. By streamlining operations across 12 strategic sites, the firm improves its margins while delivering care to millions of patients annually under its primary clinical governance.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.